Shares of Arcellx, Inc. (NASDAQ:ACLX – Get Free Report) have received a consensus recommendation of “Buy” from the fifteen ...

Guardant Health (GH) saw its shares surge in the last session with trading volume being higher than average. The latest trend ...

Generation Bio (GBIO – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Gil Blum from ...

Arcellx shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 79 to 82. On Sunday, Arcellx, Inc. (NASDAQ:ACLX) revealed new data from its Phase 2 pivotal ...

Gil Blum, an analyst from Needham, maintained the Buy rating on Taysha Gene Therapies (TSHA – Research Report). The associated price target ...

Ahead of the 2025 J.P. Morgan Healthcare Conference scheduled to take place in a few days, Oppenheimer named five potential buyout candidates in biotech on Friday, naming obesity drug developer Viking ...

Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company focusing on developing innovative immunotherapies for patients with cancer and other incurable diseases, has announced positive data from its ...

MSCI Inc. (NYSE:MSCI – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the thirteen research ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

Ahead of the 2025 J.P. Morgan Healthcare Conference scheduled to take place in a few days, Oppenheimer named five potential buyout candidates in biotech on Friday, naming obesity drug developer ...